Cargando…
Application of diffusion kurtosis imaging and (18)F-FDG PET in evaluating the subtype, stage and proliferation status of non-small cell lung cancer
BACKGROUND: Lung cancer has become one of the deadliest tumors in the world. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for approximately 80%-85% of all lung cancer cases. This study aimed to investigate the value of diffusion kurtosis imaging (DKI), diffus...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562703/ https://www.ncbi.nlm.nih.gov/pubmed/36248958 http://dx.doi.org/10.3389/fonc.2022.989131 |
_version_ | 1784808233393717248 |
---|---|
author | Feng, Pengyang Shao, Zehua Dong, Bai Fang, Ting Huang, Zhun Li, Ziqiang Fu, Fangfang Wu, Yaping Wei, Wei Yuan, Jianmin Yang, Yang Wang, Zhe Wang, Meiyun |
author_facet | Feng, Pengyang Shao, Zehua Dong, Bai Fang, Ting Huang, Zhun Li, Ziqiang Fu, Fangfang Wu, Yaping Wei, Wei Yuan, Jianmin Yang, Yang Wang, Zhe Wang, Meiyun |
author_sort | Feng, Pengyang |
collection | PubMed |
description | BACKGROUND: Lung cancer has become one of the deadliest tumors in the world. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for approximately 80%-85% of all lung cancer cases. This study aimed to investigate the value of diffusion kurtosis imaging (DKI), diffusion-weighted imaging (DWI) and 2-[(18)F]-fluoro-2-deoxy-D-glucose positron emission tomography ((18)F-FDG PET) in differentiating squamous cell carcinoma (SCC) and adenocarcinoma (AC) and to evaluate the correlation of each parameter with stage and proliferative status Ki-67. METHODS: Seventy-seven patients with lung lesions were prospectively scanned by hybrid 3.0-T chest (18)F-FDG PET/MR. Mean kurtosis (MK), mean diffusivity (MD), apparent diffusion coefficient (ADC), maximum standard uptake value (SUVmax), metabolic tumor volume (MTV) and total lesion glycolysis (TLG) were measured. The independent samples t test or Mann–Whitney U test was used to compare and analyze the differences in each parameter of SCC and AC. The diagnostic efficacy was evaluated by receiver operating characteristic (ROC) curve analysis and compared with the DeLong test. A logistic regression analysis was used for the evaluation of independent predictors. Bootstrapping (1000 samples) was performed to establish a control model, and calibration curves and ROC curves were used to validate its performance. Pearson’s correlation coefficient and Spearman’s correlation coefficient were calculated for correlation analysis. RESULTS: The MK and ADC values of the AC group were significantly higher than those of the SCC group (all P< 0.05), and the SUVmax, MTV, and TLG values of the SCC group were significantly higher than those of the AC group (all P<0.05). There was no significant difference in the MD value between the two groups. Moreover, MK, SUVmax, TLG and MTV were independent predictors of the NSCLC subtype, and the combination of these parameters had an optimal diagnostic efficacy (AUC, 0.876; sensitivity, 86.27%; specificity, 80.77%), which was significantly better than that of MK (AUC = 0.758, z = 2.554, P = 0.011), ADC (AUC = 0.679, z = 2.322, P = 0.020), SUVmax (AUC = 0.740, z = 2.584, P = 0.010), MTV (AUC = 0.715, z = 2.530, P = 0.011) or TLG (AUC = 0.716, z = 2.799, P = 0.005). The ROC curve showed that the validation model had high accuracy in identifying AC and SCC (AUC, 0.844; 95% CI, 0.785-0.885);. The SUVmax value was weakly positively correlated with the Ki-67 index (r = 0.340, P< 0.05), the ADC and MD values were weakly negatively correlated with the Ki-67 index (r = -0.256, -0.282, P< 0.05), and the MTV and TLG values were weakly positively correlated with NSCLC stage (r = 0.342, 0.337, P< 0.05). CONCLUSION: DKI, DWI and (18)F-FDG PET are all effective methods for assessing the NSCLC subtype, and some parameters are correlated with stage and proliferation status. |
format | Online Article Text |
id | pubmed-9562703 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95627032022-10-15 Application of diffusion kurtosis imaging and (18)F-FDG PET in evaluating the subtype, stage and proliferation status of non-small cell lung cancer Feng, Pengyang Shao, Zehua Dong, Bai Fang, Ting Huang, Zhun Li, Ziqiang Fu, Fangfang Wu, Yaping Wei, Wei Yuan, Jianmin Yang, Yang Wang, Zhe Wang, Meiyun Front Oncol Oncology BACKGROUND: Lung cancer has become one of the deadliest tumors in the world. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for approximately 80%-85% of all lung cancer cases. This study aimed to investigate the value of diffusion kurtosis imaging (DKI), diffusion-weighted imaging (DWI) and 2-[(18)F]-fluoro-2-deoxy-D-glucose positron emission tomography ((18)F-FDG PET) in differentiating squamous cell carcinoma (SCC) and adenocarcinoma (AC) and to evaluate the correlation of each parameter with stage and proliferative status Ki-67. METHODS: Seventy-seven patients with lung lesions were prospectively scanned by hybrid 3.0-T chest (18)F-FDG PET/MR. Mean kurtosis (MK), mean diffusivity (MD), apparent diffusion coefficient (ADC), maximum standard uptake value (SUVmax), metabolic tumor volume (MTV) and total lesion glycolysis (TLG) were measured. The independent samples t test or Mann–Whitney U test was used to compare and analyze the differences in each parameter of SCC and AC. The diagnostic efficacy was evaluated by receiver operating characteristic (ROC) curve analysis and compared with the DeLong test. A logistic regression analysis was used for the evaluation of independent predictors. Bootstrapping (1000 samples) was performed to establish a control model, and calibration curves and ROC curves were used to validate its performance. Pearson’s correlation coefficient and Spearman’s correlation coefficient were calculated for correlation analysis. RESULTS: The MK and ADC values of the AC group were significantly higher than those of the SCC group (all P< 0.05), and the SUVmax, MTV, and TLG values of the SCC group were significantly higher than those of the AC group (all P<0.05). There was no significant difference in the MD value between the two groups. Moreover, MK, SUVmax, TLG and MTV were independent predictors of the NSCLC subtype, and the combination of these parameters had an optimal diagnostic efficacy (AUC, 0.876; sensitivity, 86.27%; specificity, 80.77%), which was significantly better than that of MK (AUC = 0.758, z = 2.554, P = 0.011), ADC (AUC = 0.679, z = 2.322, P = 0.020), SUVmax (AUC = 0.740, z = 2.584, P = 0.010), MTV (AUC = 0.715, z = 2.530, P = 0.011) or TLG (AUC = 0.716, z = 2.799, P = 0.005). The ROC curve showed that the validation model had high accuracy in identifying AC and SCC (AUC, 0.844; 95% CI, 0.785-0.885);. The SUVmax value was weakly positively correlated with the Ki-67 index (r = 0.340, P< 0.05), the ADC and MD values were weakly negatively correlated with the Ki-67 index (r = -0.256, -0.282, P< 0.05), and the MTV and TLG values were weakly positively correlated with NSCLC stage (r = 0.342, 0.337, P< 0.05). CONCLUSION: DKI, DWI and (18)F-FDG PET are all effective methods for assessing the NSCLC subtype, and some parameters are correlated with stage and proliferation status. Frontiers Media S.A. 2022-09-30 /pmc/articles/PMC9562703/ /pubmed/36248958 http://dx.doi.org/10.3389/fonc.2022.989131 Text en Copyright © 2022 Feng, Shao, Dong, Fang, Huang, Li, Fu, Wu, Wei, Yuan, Yang, Wang and Wang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Feng, Pengyang Shao, Zehua Dong, Bai Fang, Ting Huang, Zhun Li, Ziqiang Fu, Fangfang Wu, Yaping Wei, Wei Yuan, Jianmin Yang, Yang Wang, Zhe Wang, Meiyun Application of diffusion kurtosis imaging and (18)F-FDG PET in evaluating the subtype, stage and proliferation status of non-small cell lung cancer |
title | Application of diffusion kurtosis imaging and (18)F-FDG PET in evaluating the subtype, stage and proliferation status of non-small cell lung cancer |
title_full | Application of diffusion kurtosis imaging and (18)F-FDG PET in evaluating the subtype, stage and proliferation status of non-small cell lung cancer |
title_fullStr | Application of diffusion kurtosis imaging and (18)F-FDG PET in evaluating the subtype, stage and proliferation status of non-small cell lung cancer |
title_full_unstemmed | Application of diffusion kurtosis imaging and (18)F-FDG PET in evaluating the subtype, stage and proliferation status of non-small cell lung cancer |
title_short | Application of diffusion kurtosis imaging and (18)F-FDG PET in evaluating the subtype, stage and proliferation status of non-small cell lung cancer |
title_sort | application of diffusion kurtosis imaging and (18)f-fdg pet in evaluating the subtype, stage and proliferation status of non-small cell lung cancer |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562703/ https://www.ncbi.nlm.nih.gov/pubmed/36248958 http://dx.doi.org/10.3389/fonc.2022.989131 |
work_keys_str_mv | AT fengpengyang applicationofdiffusionkurtosisimagingand18ffdgpetinevaluatingthesubtypestageandproliferationstatusofnonsmallcelllungcancer AT shaozehua applicationofdiffusionkurtosisimagingand18ffdgpetinevaluatingthesubtypestageandproliferationstatusofnonsmallcelllungcancer AT dongbai applicationofdiffusionkurtosisimagingand18ffdgpetinevaluatingthesubtypestageandproliferationstatusofnonsmallcelllungcancer AT fangting applicationofdiffusionkurtosisimagingand18ffdgpetinevaluatingthesubtypestageandproliferationstatusofnonsmallcelllungcancer AT huangzhun applicationofdiffusionkurtosisimagingand18ffdgpetinevaluatingthesubtypestageandproliferationstatusofnonsmallcelllungcancer AT liziqiang applicationofdiffusionkurtosisimagingand18ffdgpetinevaluatingthesubtypestageandproliferationstatusofnonsmallcelllungcancer AT fufangfang applicationofdiffusionkurtosisimagingand18ffdgpetinevaluatingthesubtypestageandproliferationstatusofnonsmallcelllungcancer AT wuyaping applicationofdiffusionkurtosisimagingand18ffdgpetinevaluatingthesubtypestageandproliferationstatusofnonsmallcelllungcancer AT weiwei applicationofdiffusionkurtosisimagingand18ffdgpetinevaluatingthesubtypestageandproliferationstatusofnonsmallcelllungcancer AT yuanjianmin applicationofdiffusionkurtosisimagingand18ffdgpetinevaluatingthesubtypestageandproliferationstatusofnonsmallcelllungcancer AT yangyang applicationofdiffusionkurtosisimagingand18ffdgpetinevaluatingthesubtypestageandproliferationstatusofnonsmallcelllungcancer AT wangzhe applicationofdiffusionkurtosisimagingand18ffdgpetinevaluatingthesubtypestageandproliferationstatusofnonsmallcelllungcancer AT wangmeiyun applicationofdiffusionkurtosisimagingand18ffdgpetinevaluatingthesubtypestageandproliferationstatusofnonsmallcelllungcancer |